entity

Epa

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Epa: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

30Hypotheses

0Analyses

5Outgoing

0Incoming

13Experiments

0Debates

No AI portrait yet

Outgoing (5)

Target	Relation	Type	Str
Inflammation	protects_against	process	0.90
Triglyceride Levels	downregulates	phenotype	0.85
Kennedy Cycle	involved_in	pathway	0.85
Major Depression	treats	disease	0.80
Neuroprotection	mediates	process	0.80

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P	0.858	ALS	-
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43	0.820	neurodegeneration	What is the therapeutic window between i
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi	0.783	neurodegeneration	-
Inhibiting Heparan Sulfate Proteoglycan Receptor-Mediated Ne	0.772	neuroscience	Trans-synaptic tau spreading and propaga
Hypothesis 3: HepaCAM-Containing Extracellular Vesicles	0.762	neurodegeneration	View

VHH-Fc Fusion Constructs with Separate BBB-Targeting Moiety	0.750	neurodegeneration	Blood-brain barrier antibody transport m
Phase-Separated Organelle Targeting	0.729	neurodegeneration	Microglia-astrocyte crosstalk amplificat
Stress Granule Phase Separation Modulators	0.720	neurodegeneration	RNA binding protein dysregulation across
TRIM21 as a 'Phase Separation Thermostat' via Catalytic Reve	0.700	neurodegeneration	How does TRIM21-mediated K63 ubiquitinat
Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mi	0.681	neurodegeneration	CRISPR-based therapeutic approaches for
Oligodendrocyte DNA Repair Enhancement Therapy	0.665	neurodegeneration	Cell type vulnerability in Alzheimer's D
Time-Dependent BBB Repair Strategy	0.656	-	Blood-brain barrier tight junction disru
p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle	0.649	neurodegeneration	How do different organelle-specific auto
Small Molecule Modulation of Phase Separation	0.640	neurodegeneration	What determines the specificity of RNA-p
Hierarchical Phase Separation with Scaffold Cores	0.630	neurodegeneration	What determines the specificity of RNA-p
Programmable Neuronal Circuit Repair via Epigenetic CRISPR	0.630	neurodegeneration	CRISPR-based therapeutic approaches for
Combine Anti-AQP4 Autoimmunity Control with Astrocyte-Endfoo	0.630	neurodegeneration	How can AQP4 be effectively targeted the
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Biophysical Determinants Shifting FUS/TD
Cell-state stratification is required to resolve Biophysical	0.612	neurodegeneration	Biophysical Determinants Shifting FUS/TD
ALS-Associated G3BP1 Mutations Shift Phase Separation Equili	0.610	neurodegeneration	How do disease-associated mutations in G
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Biophysical Determinants Shifting FUS/TD
Liquid-Liquid Phase Separation Modifier Therapy	0.551	neurodegeneration	Protein aggregation cross-seeding across
Oligodendrocyte DNA Repair Enhancement	0.550	neurodegeneration	Cell type vulnerability in Alzheimers Di
Systemic IL-6–STAT3–Hepatic C3 Axis and BBB-Mediated Complem	0.540	neuroinflammation	How does sevoflurane-induced NF-κB activ
Lysosomal Membrane Repair Enhancement	0.538	neurodegeneration	Autophagy-lysosome pathway convergence a
PI3P Generation at Damaged Lysosomes Promotes Membrane Repai	0.530	neurodegeneration	How does controlled lysosomal membrane p
Liquid-Liquid Phase Separation (LLPS) Saturation Partitionin	0.461	neurodegeneration	What determines the spatial organization
RNA Granule Phase Separation as Transient Cross-Seeding Hub	0.455	neurodegeneration	Protein aggregation cross-seeding across
Phase Separation Modulation Therapy	0.455	neurodegeneration	How do host cell factors influence the c

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (13)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
G3BP1-mediated stress granule assembly via liquid-liquid phase separat	exploratory		0.900	0.00	eukaryotic cells	proposed	N/A
TRIM21 E3 ubiquitin ligase screen for stress granule regulation	exploratory	neurodegenerative diseases	0.900	0.00	cultured cells	proposed	N/A
G3BP1 intrinsically disordered region analysis and phosphorylation eff	exploratory		0.850	0.00	in vitro protein analysis syst	proposed	N/A
G3BP1-binding factor cooperativity in stress granule network regulatio	exploratory		0.800	0.00	cell culture systems with prot	proposed	N/A
Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FTD	validation	ALS	0.400	0.50	human	proposed	$2,730,000
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Pre-Symptomatic Detection and Intervention Timing in Genetic Prion Dis	validation	ALS	0.400	0.50	human	proposed	$2,280,000
Stress Granule Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Experiment Validation: In vitro ThT Assay	validation	Alzheimer's Disease	0.400	0.50	cell_line	proposed	$160,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
Multiscale Computational Modeling of Protein Aggregation Kinetics	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,280,000
Protein Aggregation Kinetic Validation Results	validation	Neurodegeneration	0.400	0.50	in_silico	proposed	$120,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3B [PMID:36692217]	Yang C, Wang Z, Kang Y, Yi Q, Wang T, Ba	Autophagy	2023	3
G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Gran [PMID:32302571]	Yang P, Mathieu C, Kolaitis RM, Zhang P,	Cell	2020	3
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic t [PMID:32048886]	Yao RQ, Ren C, Xia ZF, Yao YM	Autophagy	2021	2
Hypoxia-driven phase separation of the PABP1/eIF4B complex forms stress granules [PMID:41780839]	Lin Z, Gao Y, Zhang Q, Yang S, Chen Y, D	Cancer Lett	2026	1
LINC00599 Promotes Pulmonary Hypertension via Liquid-Liquid Phase Separation Wit [PMID:40693377]	Wang Y, Yin L, Zheng S, Liu A, Liu C, Ba	Hypertension	2025	1
The important role of stress granules in prostate cancer development, progressio [PMID:40972860]	Xu Z, You H, Gu J, Jiang J, Yan Z, Jin X	Gene	2025	1
Membrane Atg8ylation, stress granule formation, and MTOR regulation during lysos [PMID:36394332]	Jia J, Wang F, Bhujabal Z, Peters R, Mud	Autophagy	2023	1
Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specifi [PMID:34739333]	Gwon Y, Maxwell BA, Kolaitis RM, Zhang P	Science	2021	1
STING is the scaffold protein for stress granule pre-condensation at the ER. [PMID:41917183]	Eom E, Kim J, Kim J, Kang SJ	Cell death and differentiation	2026	0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077]	["Desai M", "Gulati K", "Agrawal M", "Gh	Neural regeneration research	2026	0
WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity [PMID:41915747]	Li Z, Wang Y, Chen Z, Liu R, Lai ZH, Li	Proceedings of the National Ac	2026	0
NUP93 facilitates the nuclear import of SOX2 to activate G3BP1 transcription and [PMID:41896201]	Sun H, Yang C, Du J, Xu C, Chen Y, Chen	Cell death & disease	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Translational neurodegeneratio	2026	0
Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by sup [PMID:41920932]	Mulloy RP, Evseev D, Sharlin N, Bui-Mari	PLoS biology	2026	0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077]	Desai M, Gulati K, Agrawal M, Ghumra S,	Neural Regen Res	2026	0
Mismatch repair MLH complexes make distinct contributions to post-replicative mi [PMID:41648604]	Casazza KM, Williams GM, Johengen L, Kel	bioRxiv	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Transl Neurodegener	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Front Pharmacol	2026	0
Stress granules at the crossroads of retroviral replication and antiviral immuni [PMID:41931190]	Akbarin MM, Farjami Z, Álvarez HR	Mol Biol Rep	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Frontiers in pharmacology	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Epa in their description or question text

VHH-Fc Fusion Constructs with Separate BBB-Targeting Moiety

Score: 0.750 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The VHH-Fc fusion construct leveraging separate blood-brain barrier (BBB) targeti

Phase-Separated Organelle Targeting

Score: 0.729 · neurodegeneration · 2026-04-02

## Molecular Mechanism and Rationale Stress granules (SGs) are membraneless, phase-separated ribonucleoprotein organell

Stress Granule Phase Separation Modulators

Score: 0.720 · neurodegeneration · 2026-04-02

## Mechanistic Overview Stress Granule Phase Separation Modulators starts from the claim that modulating G3BP1 within th

TRIM21 as a 'Phase Separation Thermostat' via Catalytic Reversibility

Score: 0.700 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The TRIM21-mediated regulation of stress granule (SG) formation represents a soph

Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modula

Score: 0.681 · neurodegeneration · 2026-04-04

## Mechanistic Overview Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modulation starts from

Oligodendrocyte DNA Repair Enhancement Therapy

Score: 0.665 · neurodegeneration · 2026-04-04

## Mechanistic Overview Oligodendrocyte DNA Repair Enhancement Therapy starts from the claim that modulating PARP1 and X

Time-Dependent BBB Repair Strategy

Score: 0.656 · unknown disease · 2026-04-16

## Mechanistic Overview Time-Dependent BBB Repair Strategy starts from the claim that modulating MULTIPLE within the dis

p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinat

Score: 0.649 · neurodegeneration · 2026-04-21

## Mechanistic Overview p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinated Autophagy sta

Small Molecule Modulation of Phase Separation

Score: 0.640 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The therapeutic strategy centers on modulating liquid-liquid phase separation (LL

Hierarchical Phase Separation with Scaffold Cores

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The hierarchical phase separation model proposes a sophisticated two-tier mechani

Programmable Neuronal Circuit Repair via Epigenetic CRISPR

Score: 0.630 · neurodegeneration · 2026-04-02

## Mechanistic Overview Programmable Neuronal Circuit Repair via Epigenetic CRISPR starts from the claim that modulating

Combine Anti-AQP4 Autoimmunity Control with Astrocyte-Endfoot Repair in NMOSD

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The pathophysiology of neuromyelitis optica spectrum disorder (NMOSD) centers on

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

Cell-state stratification is required to resolve Biophysical Determinants Shifti

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: FUS, TDP-43, RNA. Averaging a